Pfizer launches virtual clinical trialBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3722 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3722
- Bob Roehr
- 1Washington, DC
The giant drug company Pfizer is conducting a “virtual” clinical trial that relies solely on electronic rather than face to face encounters between researchers and participants. It announced the trial on 7 June at a conference on clinical trials held on the Bethesda, Maryland, campus of the US National Institutes of Health.
Freda Lewis-Hall, Pfizer’s chief medical officer, said that the company is trying to reduce barriers to participation in clinical trials; to offer a consistently strong experience that does not vary by location; and potentially to save money in conducting trials in the future, if the concept proves viable.
Surveys of patients show that the …